Heartflow (HTFL) Change in Accured Expenses (2024 - 2025)
Heartflow's quarterly Change in Accured Expenses came in at $3.4 million in Q4 2025, up 1.91% year-on-year from $3.3 million in Q4 2024, and down 46.03% quarter-over-quarter from $6.2 million in Q3 2025.
Heartflow has reported Change in Accured Expenses for 2 years, with the latest figure at $3.4 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 1.91% year-over-year to $3.4 million; the trailing twelve-month figure through Dec 2025 stood at $16.9 million (changed N/A YoY), and the FY2025 full-year result was $9.3 million, up 2086.15% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at $3.4 million, down from $6.2 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $6.2 million in Q3 2025, with the low at $3.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 6.24 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 11.03 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -873,000.00 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -20.60 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -35.25 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -9.67 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -6.14 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 49.11 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | -10.77 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | 3.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.36 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Sep 30, 2025 | 6.22 Mn |
| Sep 30, 2025 | 6.22 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |